Back to User profile » Dr Sheng-Li Xue
Paper published by Dr Sheng-Li Xue:
Case Series
Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine
Zhang LS, Wang J, Xu MZ, Wu TM, Huang SM, Cao HY, Sun AN, Liu SB, Xue SL
OncoTargets and Therapy 2022, 15:159-164
Published Date: 18 February 2022